Jeffrey M. Dayno is the Chief Executive Officer and President of Harmony Biosciences. Jeffrey has held the CEO seat since 2024, and was previously Chief Medical Officer at Egalet Corporation.
Current company
Harmony Biosciences
Harmony Biosciences is a commercial-stage biopharmaceutical company dedicated to developing and delivering innovative therapies for people living with rare and other neurological diseases with unmet medical needs.
Pharmaceutical ManufacturingHeadquartered in Plymouth MeetingFounded 2017Nasdaq: HRMY
Source: Harmony Biosciences on LinkedInJeffrey M. Dayno joined Harmony Biosciences in November 2017 and has been CEO since 2024. Before Harmony Biosciences, Jeffrey was Chief Medical Officer at Egalet Corporation from July 2014 until November 2017.
Career
Sources: LinkedIn profile
Education
Trinity College-Hartford, Bachelor of Arts (B.A.), International/Global StudiesTemple University School of Medicine, Doctor of Medicine (MD), MedicineSource
20+ decision makers at Harmony Biosciences in Unify, vice president level and above. Choose a function to see who leads it.
Top decision makers at Harmony Biosciences
Vice president level and above, most senior firstJeffrey M. Dayno leads a leadership team of 11 published executives.
Most senior 5 of 11
| Name | Title | In seat since |
|---|---|---|
| Jeffrey M. Dayno | President and Chief Executive Officer | 2024 |
| Peter Anastasiou | Chief Operating Officer | Not stated |
| Christian Ulrich | Executive Vice President, General Counsel & Corporate Secretary | Not stated |
| Kumar Budur | Chief Medical and Scientific Officer | Not stated |
| Adam Zaeske | Executive Vice President and Chief Commercial Officer | Not stated |
Jeffrey M. Dayno is the Chief Executive Officer and President of Harmony Biosciences. Jeffrey has held the CEO seat since 2024, and was previously Chief Medical Officer at Egalet Corporation.
Jeffrey M. Dayno has been CEO of Harmony Biosciences since 2024, according to LinkedIn profile.
Jeffrey M. Dayno was Chief Medical Officer at Egalet Corporation from July 2014 until November 2017, according to LinkedIn profile.
Jeffrey M. Dayno has been CEO of Harmony Biosciences for 2 years, since 2024.
Peter Anastasiou (Chief Operating Officer), Christian Ulrich (Executive Vice President, General Counsel & Corporate Secretary), Kumar Budur (Chief Medical and Scientific Officer), Adam Zaeske (Executive Vice President and Chief Commercial Officer), and 6 more. Source: Harmony Biosciences senior leadership page.
The seat holder is identified in Unify's professional profile dataset, then confirmed against the company's published leadership page, its SEC filings, and Wikipedia before publication. Career and education rows carry the public document they were taken from. Leadership team membership follows the company's own leadership page; in-seat dates come from filings where available and otherwise from the profile record. Company figures are read from the Unify headcount page for the same company and are profile coverage measures, never company-reported workforce totals. The employee preview lists vice president and senior vice president level profiles by department. No personal contact details are published.
